Variant report
Variant | nsv599561 |
---|---|
Chromosome Location | chr5:118043996-118073157 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DTWD2-6 | chr5:118060533-118060627 | l_3003_chr5:118060532-118101249_testes |
2 | lnc-DTWD2-6 | chr5:118061438-118061520 | l_3003_chr5:118060532-118101249_testes |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561712618 | chr5:118047433-118047434 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76881881 | chr5:118047440-118047441 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182742035 | chr5:118047456-118047457 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557177316 | chr5:118047469-118047470 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570519713 | chr5:118047471-118047472 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563462660 | chr5:118047548-118047549 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371535197 | chr5:118047551-118047552 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539640538 | chr5:118047652-118047653 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573839160 | chr5:118047691-118047692 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187383619 | chr5:118047697-118047698 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534689721 | chr5:118047734-118047735 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554590954 | chr5:118047749-118047750 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
13 | rs151017481 | chr5:118057802-118057803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376836566 | chr5:118057809-118057810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs57208269 | chr5:118057813-118057814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182370076 | chr5:118057868-118057869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553937953 | chr5:118057890-118057891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574110760 | chr5:118057956-118057957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141726679 | chr5:118057994-118057995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs735620 | chr5:118058065-118058066 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs369662885 | chr5:118058105-118058106 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6894241 | chr5:118058126-118058127 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs187360800 | chr5:118058132-118058133 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565260097 | chr5:118058187-118058188 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190163461 | chr5:118058196-118058197 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181484056 | chr5:118058206-118058207 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567629558 | chr5:118058221-118058222 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147093580 | chr5:118058293-118058294 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538646957 | chr5:118058319-118058320 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs141351492 | chr5:118058323-118058324 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76324203 | chr5:118058344-118058345 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549502122 | chr5:118058471-118058472 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114546564 | chr5:118058517-118058518 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376925695 | chr5:118058526-118058527 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186118202 | chr5:118058527-118058528 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553754345 | chr5:118058570-118058571 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs138517640 | chr5:118058580-118058581 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144102836 | chr5:118058581-118058582 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs730907 | chr5:118058631-118058632 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | mRNA abundance |
40 | rs548389935 | chr5:118058638-118058639 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143212037 | chr5:118058653-118058654 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150084255 | chr5:118058663-118058664 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs75795300 | chr5:118058682-118058683 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536403163 | chr5:118058692-118058693 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs730906 | chr5:118058726-118058727 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs78560031 | chr5:118058734-118058735 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs577415209 | chr5:118058760-118058761 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs558808818 | chr5:118058770-118058771 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs117511833 | chr5:118058783-118058784 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs730909 | chr5:118058845-118058846 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22543975 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:118047400-118047800 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr5:118047400-118047800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr5:118057800-118058000 | Enhancers | GM12878-XiMat | blood |
4 | chr5:118058000-118058400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
5 | chr5:118058000-118059200 | Flanking Active TSS | GM12878-XiMat | blood |
6 | chr5:118058200-118059200 | Enhancers | Fetal Lung | lung |
7 | chr5:118058400-118062400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
8 | chr5:118058600-118059400 | Enhancers | HSMMtube | muscle |
9 | chr5:118059200-118059600 | Enhancers | GM12878-XiMat | blood |
10 | chr5:118059200-118062800 | Weak transcription | Fetal Lung | lung |
11 | chr5:118062400-118063000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
12 | chr5:118062800-118063000 | Enhancers | Fetal Lung | lung |
13 | chr5:118064000-118064600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr5:118064000-118064600 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr5:118064000-118064600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr5:118064200-118064600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr5:118070400-118070800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |